ICU Medical, Incorporated (ICUI) Shares Bought by Capital Fund Management S.A.
Capital Fund Management S.A. boosted its position in ICU Medical, Incorporated (NASDAQ:ICUI) by 238.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,100 shares of the medical instruments supplier’s stock after acquiring an additional 4,300 shares during the quarter. Capital Fund Management S.A.’s holdings in ICU Medical were worth $1,791,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently modified their holdings of the stock. Mackay Shields LLC acquired a new position in shares of ICU Medical during the second quarter worth about $205,000. Eagle Boston Investment Management Inc. acquired a new position in shares of ICU Medical during the first quarter worth about $206,000. CIBC Asset Management Inc acquired a new position in shares of ICU Medical during the second quarter worth about $209,000. LPL Financial LLC acquired a new position in shares of ICU Medical during the first quarter worth about $218,000. Finally, Campbell & CO Investment Adviser LLC acquired a new position in shares of ICU Medical during the second quarter worth about $230,000. Hedge funds and other institutional investors own 74.30% of the company’s stock.
In other news, VP Virginia Ruth Sanzone sold 787 shares of ICU Medical stock in a transaction dated Tuesday, August 28th. The stock was sold at an average price of $303.12, for a total transaction of $238,555.44. Following the sale, the vice president now directly owns 1,367 shares of the company’s stock, valued at $414,365.04. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director George A. Lopez sold 22,204 shares of ICU Medical stock in a transaction dated Tuesday, July 3rd. The stock was sold at an average price of $291.15, for a total value of $6,464,694.60. Following the sale, the director now directly owns 387,875 shares in the company, valued at $112,929,806.25. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 843,458 shares of company stock worth $242,013,941. 12.50% of the stock is currently owned by insiders.
Shares of ICUI opened at $282.85 on Friday. The stock has a market cap of $6.19 billion, a price-to-earnings ratio of 41.93 and a beta of 0.36. ICU Medical, Incorporated has a 12 month low of $179.80 and a 12 month high of $321.70.
ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings data on Thursday, August 9th. The medical instruments supplier reported $2.66 EPS for the quarter, topping the Zacks’ consensus estimate of $1.82 by $0.84. The company had revenue of $360.46 million for the quarter, compared to analysts’ expectations of $337.60 million. ICU Medical had a return on equity of 12.78% and a net margin of 5.93%. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.76 earnings per share. sell-side analysts expect that ICU Medical, Incorporated will post 7.6 EPS for the current year.
About ICU Medical
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Further Reading: Market Capitalization in the Stock Market
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.